Veeva Systems (NYSE: VEEV) shares rose sharply Monday following the announcement of its new Veeva Falcon AI platform. The stock's gains reflect investor optimism regarding the company's expanding artificial intelligence portfolio ahead of its quarterly earnings report.
Veeva Falcon is an agentic platform designed to automate major drug development processes for life sciences companies. The system integrates with the Veeva Development Cloud to reduce costs and increase speed while maintaining compliance in clinical, regulatory, and safety operations.
The platform is scheduled for release to early adopters in November 2026.